Proarrhythmia

From Wikipedia, the free encyclopedia

Proarrhythmia is a new or more frequent occurrence of pre-existing arrhythmias, paradoxically precipitated by antiarrhythmic therapy, which means it is a side-effect associated with the administration of some existing antiarrhythmic drugs, as well as drugs for other indications. In other words, it is a tendency of antiarrhythmic drugs to facilitate emergence of new arrhythmias.

Contents

[edit] Types of Proarrhythmia

According to the Vaughan Williams classification (VW) of antiarrhythmic drugs, there are 3 main types of Proarrhythmia during treatment with various antiarrhythmic drugs for Atrial Fibrillation or Atrial flutter:

[edit] Ventricular proarrhythmia

[edit] Atrial proarrhythmia

  • Conversion of atrial fribrillation to flutter (usually VW type IC drugs or amiodarone). May be a desired effect.
  • Increase of defibrillation threshold (a potential problem with VW type IC drugs)
  • Provocation of recurrence (probably VW types IA, IC and III drugs). It is rare.

[edit] Abnormalities of conduction or impulse formation

[edit] Increased risk

  • Presence of structural heart disease, especially LV systolic dysfunction.
  • Class IC agents.
  • Increased age.
  • Females.

[edit] Clinical pointers

[edit] Class IA drugs

  • Dose independent, occurring at normal levels.
  • Follow QT interval, keep ms.

[edit] Class IC drugs

  • May be provoked by increased heart rate.
  • Exercise stress tests after loading.

[edit] Class III drugs

  • Dose dependent.
  • Follow bradycardia, prolonged QT closely.

[edit] External links